Iain Stuart
2023
In 2023, Iain Stuart earned a total compensation of $1.2M as Chief Scientific Officer at VYNE Therapeutics, a 78% increase compared to previous year.
Compensation breakdown
| Bonus | $168,724 |
|---|---|
| Non-Equity Incentive Plan | $253,086 |
| Option Awards | $139,375 |
| Salary | $421,811 |
| Stock Awards | $168,750 |
| Other | $13,200 |
| Total | $1,164,946 |
Stuart received $421.8K in salary, accounting for 36% of the total pay in 2023.
Stuart also received $168.7K in bonus, $253.1K in non-equity incentive plan, $139.4K in option awards, $168.8K in stock awards and $13.2K in other compensation.
Rankings
In 2023, Iain Stuart's compensation ranked 1,049th out of 3,006 executives tracked by ExecPay. In other words, Stuart earned more than 65.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,049 out of 3,006 | 65th |
Division Manufacturing | 624 out of 1,650 | 62nd |
Major group Chemicals And Allied Products | 430 out of 918 | 53rd |
Industry group Drugs | 419 out of 881 | 52nd |
Industry Pharmaceutical Preparations | 286 out of 637 | 55th |
Source: SEC filing on November 12, 2024.
Stuart's colleagues
We found two more compensation records of executives who worked with Iain Stuart at VYNE Therapeutics in 2023.